These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38058983)

  • 1. Immunization with Embryonic Stem Cells/Induced Pluripotent Stem Cells Induces Effective Immunity against Ovarian Tumor-Initiating Cells in Mice.
    Yu F; Zhang Z; Chang X; Ye X; Cheng H; Li Y; Cui H
    Stem Cells Int; 2023; 2023():8188324. PubMed ID: 38058983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer stem cell vaccination confers significant antitumor immunity.
    Ning N; Pan Q; Zheng F; Teitz-Tennenbaum S; Egenti M; Yet J; Li M; Ginestier C; Wicha MS; Moyer JS; Prince ME; Xu Y; Zhang XL; Huang S; Chang AE; Li Q
    Cancer Res; 2012 Apr; 72(7):1853-64. PubMed ID: 22473314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Genetic Melanoma Vaccines Based on Induced Pluripotent Stem Cells or Melanosphere-Derived Stem-Like Cells Display High Efficacy in a Murine Tumor Rejection Model.
    Gąbka-Buszek A; Kwiatkowska-Borowczyk E; Jankowski J; Kozłowska AK; Mackiewicz A
    Vaccines (Basel); 2020 Mar; 8(2):. PubMed ID: 32224883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different pancreatic cancer microenvironments convert iPSCs into cancer stem cells exhibiting distinct plasticity with altered gene expression of metabolic pathways.
    Hassan G; Ohara T; Afify SM; Kumon K; Zahra MH; Fu X; Al Kadi M; Seno A; Salomon DS; Seno M
    J Exp Clin Cancer Res; 2022 Jan; 41(1):29. PubMed ID: 35063003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eliciting effective tumor immunity against ovarian cancer by cancer stem cell vaccination.
    Xu H; Zhao F; Wu D; Zhang Y; Bao X; Shi F; Cai Y; Dou J
    Biomed Pharmacother; 2023 May; 161():114547. PubMed ID: 36933377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A real-time pluripotency reporter for the long-term and real-time monitoring of pluripotency changes in induced pluripotent stem cells.
    Shen HF; Li YL; Huang SH; Xia JW; Yao ZF; Xiao GF; Zhou Y; Li YC; Shi JW; Lin XL; Zhao WT; Sun Y; Tian YG; Jia JS; Xiao D
    Aging (Albany NY); 2022 May; 14(10):4445-4458. PubMed ID: 35575836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying Candidate Reprogramming Genes in Mouse Induced Pluripotent Stem Cells.
    Gao F; Li J; Zhang H; Yang X; An T
    Stem Cell Rev Rep; 2017 Aug; 13(4):532-541. PubMed ID: 28063063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventive cancer stem cell-based vaccination modulates tumor development in syngeneic colon adenocarcinoma murine model.
    Eini L; Naseri M; Karimi-Busheri F; Bozorgmehr M; Ghods R; Madjd Z
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):4101-4116. PubMed ID: 36040667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination with embryonic stem cells generates effective antitumor immunity against ovarian cancer.
    Zhang Z; Chen X; Chang X; Ye X; Li Y; Cui H
    Int J Mol Med; 2013 Jan; 31(1):147-53. PubMed ID: 23174760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer stem cell induction from mouse embryonic stem cells.
    Seno A; Murakami C; El-Aarag B; Iwasaki Y; Ohara T; Seno M
    Oncol Lett; 2019 Sep; 18(3):2756-2762. PubMed ID: 31452753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Epitope Basis of Embryonic Stem Cell-Induced Antitumor Immunity against Bladder Cancer.
    Jin M; Hu J; Tong L; Zhang BZ; Huang JD
    Adv Healthc Mater; 2023 Apr; 12(9):e2202691. PubMed ID: 36510117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signaling Inhibitors Accelerate the Conversion of mouse iPS Cells into Cancer Stem Cells in the Tumor Microenvironment.
    Du J; Xu Y; Sasada S; Oo AKK; Hassan G; Mahmud H; Khayrani AC; Alam MJ; Kumon K; Uesaki R; Afify SM; Mansour HM; Nair N; Zahra MH; Seno A; Okada N; Chen L; Yan T; Seno M
    Sci Rep; 2020 Jun; 10(1):9955. PubMed ID: 32572057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cell based immunotherapy using tumor stem cells mediates potent antitumor immune responses.
    Dashti A; Ebrahimi M; Hadjati J; Memarnejadian A; Moazzeni SM
    Cancer Lett; 2016 Apr; 374(1):175-185. PubMed ID: 26803056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen-specific T-cell response from dendritic cell vaccination using cancer stem-like cell-associated antigens.
    Xu Q; Liu G; Yuan X; Xu M; Wang H; Ji J; Konda B; Black KL; Yu JS
    Stem Cells; 2009 Aug; 27(8):1734-40. PubMed ID: 19536809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reprogramming- and pluripotency-associated membrane proteins in mouse stem cells revealed by label-free quantitative proteomics.
    Hao J; Li W; Dan J; Ye X; Wang F; Zeng X; Wang L; Wang H; Cheng Y; Liu L; Shui W
    J Proteomics; 2013 Jun; 86():70-84. PubMed ID: 23615220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression levels of a gene signature in hiPSC associated with lung adenocarcinoma stem cells and its capability in eliciting specific antitumor immune-response in a humanized mice model.
    Wang J; Shao L; Wu L; Ma W; Zheng Y; Hu C; Li F
    Thorac Cancer; 2020 Jun; 11(6):1603-1612. PubMed ID: 32314522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A model of cancer stem cells derived from mouse induced pluripotent stem cells.
    Chen L; Kasai T; Li Y; Sugii Y; Jin G; Okada M; Vaidyanath A; Mizutani A; Satoh A; Kudoh T; Hendrix MJ; Salomon DS; Fu L; Seno M
    PLoS One; 2012; 7(4):e33544. PubMed ID: 22511923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concise Review: Targeting Cancer Stem Cells Using Immunologic Approaches.
    Pan Q; Li Q; Liu S; Ning N; Zhang X; Xu Y; Chang AE; Wicha MS
    Stem Cells; 2015 Jul; 33(7):2085-92. PubMed ID: 25873269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic Cells Derived from Cancer Stem Cells Generated from Mouse Induced Pluripotent Stem Cells.
    Hassan G; Afify SM; Nair N; Kumon K; Osman A; Du J; Mansour H; Abu Quora HA; Nawara HM; Satoh A; Zahra MH; Okada N; Seno A; Seno M
    Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31905766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overlapping genes may control reprogramming of mouse somatic cells into induced pluripotent stem cells (iPSCs) and breast cancer stem cells.
    Mosca E; Cocola C; Sabour D; Pelucchi P; Bertalot G; Palumbo O; Carella M; Götte M; Schöler HR; Reinbold R; Zucchi I; Milanesi L
    In Silico Biol; 2010; 10(5-6):207-21. PubMed ID: 22430355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.